Author(s)

Eduardo Cervera, Federico Godínez, Rosa Sosa, Ramón Rivas, Carlos Best, Juan Hernández, Adrián Morales, Hugo Zurita, Ivette Carrasco, Jorge Cruz, Álvaro Aguayo, José Espinoza, Juan Labardini, Luis Valero, Judith Cruz, Diana Arcos, Diego Limón, Omar López-Navarro, Daniela Gordillo-Bastidas, Myrna Candelaria, Francisco Torres, Juan Kassack, Oscar de Jesús Pérez Ramírez, Jorge Aquino, Guillermo Díaz, Mariela Cardiel, Margarita Rodríguez, Patricia Montoya, Juan Contreras, María Chávez, Sandra Chávez, David Gómez, Olga Cantú, Jorge Duque, Luis Pita, Eduardo Lobato, Julio López, Antonio López, Pedro González, Jorge Cortés

Haematology and Oncology Department, National Institute of Medical and Nutrition Sciences “Dr. Salvador Zubirán”, Mexico City, Mexico.
Haematology Deparment from Hospital Juárez, Mexico City, Mexico.
Haematology Department, Blood Bank and Unit of Aphaeresis, General Hospital of Culiacán, Health Ministry, Culiacán, Mexico.
Haematology Department, Bone Marrow Transplant, and Blood Bank from Hospital Regional de Alta Especialidad “Dr. Juan Graham Casassus”, Villahermosa, Mexico.
Haematology Department, Cancerology National Institute (INCan), Mexico City, Mexico.
Haematology Department, Cancerology National Institute (INCan), Mexico City, Mexico; 2Internal Medicine, Haematology, Hospital ISSSTECALI, Tijuana, Mexico.
Haematology Department, Centenario Hospital, Miguel Hidalgo, Health Ministry, Aguascalientes, Mexico.
Haematology Department, General Hospital of Sonora State, Sonora, Mexico.
Haematology Department, Hospital Universitario UANL, Monterrey, Mexico.
Haematology, Haematology Service, Hospital General Regional SSG, León, Mexico.
Haematology, Head of Haematology Service, School of Medicine, Autonomous University of San Luis Potosí, San Luis Potosí, Mexico.
Haematology, Hospital “Aranda de la Parra”, León, Mexico.
Haematology, Hospital General de Especialidades, Campeche, Mexico.
Haematology, Hospital General de México, Mexico City, Mexico.
Haematology, Hospital General de Occidente SSA, Guadalajara, Mexico.
Haematology, Hospital Regional de Alta Especialidad de Oaxaca, Oaxaca, Mexico.
Haematology, Mérida Clinic, Yucatán, Mexico.
Haematology, Oncology Unit, SSEP, Puebla, Mexico.
Hospital Betania, Puebla, Mexico.
Hospital of the Poblano Child, Puebla, Mexico.
Internal Medicine, Haematology, Hospital ISSSTECALI, Tijuana, Mexico.
Leukaemias Clinic at ISSEMyM, Toluca, Mexico.
Leukemia Department, MD Anderson Cancer Center, Houston, Mexico.
Los Mochis General Hospital, Sinaloa, Mexico.
Renaissance Clinic, Morelia, Mexico.
State Council for AIDS Prevention and Control, Chihuahua, Mexico.
Universidad Autónoma de Yucatán, Mérida, Mexico.

Background: This document includes recommendations and guidelines issued by a group of Mexican researchers and specialists gathered in the First National Colloquium for the Diagnosis and Management of Chronic Myeloid Leukaemia (CML) by initiative of Instituto Nacional de Cancerología and with the support of the Leukaemia Department of the MD Anderson Cancer Center. Mexico lacks of updated information taken from its own reality on the diagnosis and treatment of CML and other haematological disorders; besides, there are no national guidelines. Aim: To publish a consensus document with guidelines for the management of CML adjusted to the national environment and overall characteristics. Method: The participants answered a DELPHI questionnaire about the overall aspects of the disease, aiming to target controversial topics, discuss them in the colloquium, and to agree on the best ones. After those meetings, a final document was drawn up. Results: The group presents recommendations for definition, diagnosis, prognosis, monitoring, and treatment of CML in Mexico. Conclusions: Having consensus guidelines for the clinical management of CML in our country will enable the consensual practice of Mexican specialists regarding the clinical approach to CML, as well as optimize the resources which allow the rational planning of the medical care strategies.

Chronic Myeloid Leukaemia; Management Guidelines; Diagnosis; Treatment.

E. Cervera, F. Godínez, R. Sosa, R. Rivas, C. Best, J. Hernández, A. Morales, H. Zurita, I. Carrasco, J. Cruz, Á. Aguayo, J. Espinoza, J. Labardini, L. Valero, J. Cruz, D. Arcos, D. Limón, O. López-Navarro, D. Gordillo-Bastidas, M. Candelaria, F. Torres, J. Kassack, O. Ramírez, J. Aquino, G. Díaz, M. Cardiel, M. Rodríguez, P. Montoya, J. Contreras, M. Chávez, S. Chávez, D. Gómez, O. Cantú, J. Duque, L. Pita, E. Lobato, J. López, A. López, P. González and J. Cortés, "Mexican Guidelines for the Diagnosis and Treatment of Chronic Myeloid Leukaemia," Journal of Cancer Therapy, Vol. 4 No. 3, 2013, pp. 747-764. doi: 10.4236/jct.2013.43092.